Table 2. Pooled Estimates of Performance Indicators for FIT and Colonoscopy-Based Programs.
Variable | Studies, No. | Population, No. | Positive test, No. | Range, % | Point estimate, % (95% CI)a |
---|---|---|---|---|---|
Participation rate | |||||
Overall | 12 | 118 780 | 105 971 | 44.5-92.8 | 85.8 (78.5-91.4) |
Voluntary | 5 | 45 699 | 40 513 | 77.8-98.2 | 86.4 (80.9-91.1) |
Population-based | 4 | 19 039 | 17 224 | 44.5-92.82 | 83 (58.9-97.7) |
Convenience | 3 | 54 042 | 48 234 | 88.4-91.24 | 89.7 (86.8-92.3) |
FIT positivity rate | |||||
Overall | 12 | 105 971 | 12 377 | 5.9-24.9 | 11.6 (8.7-14.8) |
50 ng/dL | 5 | 18 172 | 3232 | 9.6-24.9 | 15.2 (9.6-21.8) |
100 ng/dL | 5 | 40 513 | 5344 | 5.9-15.2 | 9.7 (6.8-13.0) |
Not reported | 2 | 47 286 | 3801 | 8.0-9.1 | 8 (7.8-8.2) |
Detection rates per positive FITb | |||||
ADR | 12 | 12 377 | 3377 | 5.5-55.07 | 28.5 (19.1-38.8) |
AADR | 8 | 7788 | 282 | 1.1-28.2 | 8.3 (3.5-14.9) |
CRC detection rate | 12 | 12 377 | 410 | 0.0-12.0 | 3.5 (1.6-6.0) |
Any adenoma (ADR) | |||||
FIT-positivec | 12 | 9373 | 3377 | 13.9-65.0 | 39 (29.3-49.2) |
Screening colonoscopy | 4 | 3494 | 699 | 16.6-26.1 | 19.9 (15.5-24.8) |
Advance Adenoma (AADR) | |||||
FIT-positivec | 10 | 7240 | 648 | 2.2-34.5 | 13.3 (7.4-20.5) |
Screening colonoscopy | 2 | 2258 | 62 | 2.6-3.9 | 2.9 (1.8-4.3) |
CRC detection rate | |||||
FIT-positivec | 12 | 9373 | 420 | 0.0-15.1 | 5.4 (3.1-8.2) |
Screening colonoscopy | 4 | 3494 | 15 | 0.0-1.3 | 0.4 (0.1-0.8) |
Colonoscopy quality indicators | |||||
Cecal intubation rate | 12 | 12 203 | 11 515 | 86.8-100.0 | 95.7 (92.7-97.9) |
Withdrawal time, mean, min | 4 | 4825 | 9.9 | 7.3-17.0 | 8.4 (4.3-12.4) |
Bowel preparation (adequate) | 4 | 6459 | 6109 | 83.5-99.6 | 94.6 (86.6-99.5) |
Abbreviations: AADR, advanced adenoma detection rate; ADR, adenoma detection rate (any adenoma); CRC, colorectal cancer; FIT, fecal immunochemical test.
Random-effects meta-analysis of proportions.
In FIT-based programs.
Rates per colonoscopy after positive FIT, from FIT-based programs only.